2252.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 03:35):

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe...

Stats
Dagens volum	47 500.00
Gjennomsnittsvolum	1.12M
Markedsverdi	13.12B
EPS	HKD0 ( 2024-03-29 )
Neste inntjeningsdato	( HKD0 ) 2024-06-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-11.98
ATR14	HKD0.0220 (0.16%)

Volum Korrelasjon

Lang: 0.07 (neutral)

Kort: 0.32 (neutral)

Signal:(75.516) Neutral

Shanghai MicroPort MedBot Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Shanghai MicroPort MedBot Korrelasjon - Valuta/Råvare

0.08
( neutral )

0.26
( neutral )

0.00
( neutral )

-0.51
( weak negative )

0.10
( neutral )

0.17
( neutral )

Shanghai MicroPort MedBot Økonomi

Annual	2023
Omsetning:	HKD104.59M
Bruttogevinst:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2023
Omsetning:	HKD104.59M
Bruttogevinst:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2022
Omsetning:	HKD21.60M
Bruttogevinst:	HKD6.56M (30.38 %)
EPS:	HKD-1.220

FY	2021
Omsetning:	HKD2.15M
Bruttogevinst:	HKD919 000 (42.74 %)
EPS:	HKD-0.612

Financial Reports:

No articles found.

Shanghai MicroPort MedBot

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; Honghu, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and automated needle targeting robotics systems for percutaneous lung biopsy and percutaneous nephrolithotomy. Shanghai Microport Medbot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai Microport Medbot (Group) Co., Ltd. operates as a subsidiary of MicroPort Scientific Corporation.